Figure 1From: A clinical protocol to inhibit the HGF/c-Met pathway for malignant mesothelioma with an intrapleural injection of adenoviruses expressing the NK4 geneA diagram of the study design. Enrollment of a patient needs more than 4 weeks after the last chemotherapy. Ad-NK4 is injected into the pleural cavity and then the patient will be monitored. The clinical study ends after day 29 but we will follow-up the patient thereafter.Back to article page